SCHEMBL28021174

SCHEMBL28021174

O=C(O)C1CCCC=C1S(=O)(=O)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 3/20 0.41
HPGD P15428 3/20 0.38
USP2 O75604 1/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HTR6 P50406 1/20 0.36
TAS2R14 Q9NYV8 1/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA12 O43570 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27727847 0.69 TSHR (0.41) TSHRSMN1; SMN2HSD17B10HPGDUSP2
SCHEMBL10361250 0.67 CHRM2 (0.40) SMN1; SMN2NPC1RAB9AALDH1A1NPSR1
Hydrochloric Acid SCHEMBL10361248 0.66 CHRM2 (0.39) SMN1; SMN2NPC1RAB9AALDH1A1NPSR1
SCHEMBL6266290 0.65 HDAC1 (0.40) HSD17B10HPGDCA1CA2ALDH1A1
Phenylmethanesulfonic Acid SCHEMBL29785797 0.65 ALDH1A1 (0.49) TSHRSMN1; SMN2HSD17B10HPGDUSP2
SCHEMBL9322782 0.64 TSHR (0.49) TSHRSMN1; SMN2HSD17B10HPGDCA1
SCHEMBL31515163 0.63 TSHR (0.41) TSHRSMN1; SMN2HSD17B10HPGDUSP2
SCHEMBL164696 0.62 SIRT1 (0.32) ALDH1A1
SCHEMBL8041723 0.62 SIRT1 (0.35)
SCHEMBL312941 0.62 TSHR (1.00) TSHRSMN1; SMN2HSD17B10HPGDCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104744321-A Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent TAKEDA PHARMACEUTICAL 2015-07-01 CN disclosed